This study aimed to determine the prevalence of electrolyte disorders in patients hospitalized in the oncology department of a Senegalese hospital. Through a retrospective cross-sectional analysis of 160 patient records over a two-year period, the authors found a high prevalence of these disorders (80.6%). Hyponatremia was the most common disorder (51.5%), with the highest rates observed in patients with stomach cancer.
References
[1]
Li, Y., Chen, X., Shen, Z., Wang, Y., Hu, J., Xu, J., et al. (2020) Electrolyte and Acid-Base Disorders in Cancer Patients and Its Impact on Clinical Outcomes: Evidence from a Real-World Study in China. Renal Failure, 42, 234-243. https://doi.org/10.1080/0886022x.2020.1735417
[2]
Khan, M.I., Dellinger, R.P. and Waguespack, S.G. (2018) Electrolyte Disturbances in Critically Ill Cancer Patients: An Endocrine Perspective. Journal of Intensive Care Medicine, 33, 147-158. https://doi.org/10.1177/0885066617706650
[3]
Ratanasrimetha, P., Workeneh, B.T. and Seethapathy, H. (2022) Sodium and Potassium Dysregulation in the Patient with Cancer. Advances in Chronic Kidney Disease, 29, 171-179.e1. https://doi.org/10.1053/j.ackd.2022.01.003
[4]
Workeneh, B.T., Jhaveri, K.D. and Rondon-Berrios, H. (2020) Hyponatremia in the Cancer Patient. Kidney International, 98, 870-882. https://doi.org/10.1016/j.kint.2020.05.015
[5]
Rose, P.G., Ali, S., Whitney, C.W., Lanciano, R. and Stehman, F.B. (2010) Impact of Hydronephrosis on Outcome of Stage IIIB Cervical Cancer Patients with Disease Limited to the Pelvis, Treated with Radiation and Concurrent Chemotherapy: A Gynecologic Oncology Group Study. Gynecologic Oncology, 117, 270-275. https://doi.org/10.1016/j.ygyno.2010.01.045
[6]
Patel, K., Foster, N.R., Kumar, A., Grudem, M., Longenbach, S., Bakkum-Gamez, J., et al. (2015) Hydronephrosis in Patients with Cervical Cancer: An Assessment of Morbidity and Survival. Supportive Care in Cancer, 23, 1303-1309. https://doi.org/10.1007/s00520-014-2482-y
[7]
Kbirou, A., Sayah, M., Sounni, F., Zamd, M., Benghanem, M.G., Dakir, M., et al. (2022) Obstructive Oligo-Anuria Revealing Pelvic Gynecological Cancers, Analysis of a Series of 102 Cases. Annals of Medicine & Surgery, 75, Article 103332. https://doi.org/10.1016/j.amsu.2022.103332
[8]
Bharti, A., et al. (2020) Electrolyte Disorders in Cancer Patients. International Journal of Scientific Research, 9, 29-31.
[9]
Berghmans, T., Paesmans, M. and Body, J.-J. (2000) A Prospective Study on Hyponatraemia in Medical Cancer Patients: Epidemiology, Aetiology and Differential Diagnosis. Supportive Care in Cancer, 8, 192-197. https://doi.org/10.1007/s005200050284
[10]
Ellison, D.H. and Berl, T. (2007) The Syndrome of Inappropriate Antidiuresis. New England Journal of Medicine, 356, 2064-2072. https://doi.org/10.1056/nejmcp066837
[11]
Berardi, R., Torniai, M., Lenci, E., Pecci, F., Morgese, F. and Rinaldi, S. (2019) Electrolyte Disorders in Cancer Patients: A Systematic Review. Journal of Cancer Metastasis and Treatment, 2019, Article No. 79. https://doi.org/10.20517/2394-4722.2019.008
[12]
Grasso, S., Ferro, Y., Migliaccio, V., Mazza, E., Rotundo, S., Pujia, A., et al. (2013) Hypokalemia during the Early Phase of Refeeding in Patients with Cancer. Clinics, 68, 1413-1415. https://doi.org/10.6061/clinics/2013(11)05
[13]
Shrimanker, I. and Bhattarai, S. (2023) Electrolytes. StatPearls Publishing. http://www.ncbi.nlm.nih.gov/books/NBK541123/
[14]
Adeyinka, A. and Bashir, K. (2023) Tumor Lysis Syndrome. StatPearls Publishing. http://www.ncbi.nlm.nih.gov/books/NBK518985/
[15]
Yunos, N.M., Kim, I.B., Bellomo, R., Bailey, M., Ho, L., Story, D., et al. (2011) The Biochemical Effects of Restricting Chloride-Rich Fluids in Intensive Care. Critical Care Medicine, 39, 2419-2424. https://doi.org/10.1097/ccm.0b013e31822571e5
[16]
Adrogué, H.J. and Madias, N.E. (2000) Hypernatremia. New England Journal of Medicine, 342, 1493-1499. https://doi.org/10.1056/nejm200005183422006
